About

Farid Seddighi, PhD, has been Head of the Device Project Group at Gerresheimer Advanced Technology since January 2021 and is responsible for the development of medical devices in the regulated area. Dr Seddighi studied Physics in Kiel (Germany) and Bern (Switzerland). He has experience in development processes in basic research (NASA), as well as in the laser and semiconductor industry (Carl Zeiss AG), and in the development and lifecycle management of insulin pens and autoinjectors for biologics (Sanofi).

Contributions

INJECTION

COMPREHENSIVE TESTING PROVES DESIGN CONCEPT OF NOVEL AUTOINJECTOR PLATFORM

Farid Seddighi, Sigrid Saaler-Reinhardt and Daniel Primavessy discuss the critical importance of testing at an early stage of medical device development, presenting an overview of the results that confirm the technical performance and usability of the novel Gx Inbeneo^® autoinjector.